Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
1.770
+0.050 (2.91%)
Aug 3, 2026, 2:27 PM EDT - Market open
Microbot Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Microbot Medical stock has a consensus rating of "Strong Buy" and an average price target of $7.00. The average 1-year stock price forecast is 295.48% higher than the current stock price, while the lowest is $4.00 (+125.99%) and the highest is $12 (+577.97%).
Price Target: $7.00 (+295.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Microbot Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +577.97% | Jul 13, 2026 |
Unknown Analyst Lucid Capital No rating | Lucid Capital | Buy Initiates $4 | Buy | Initiates | $4 | +125.99% | Jun 3, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $5.5 | Buy | Reiterates | $5.5 | +210.73% | Apr 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $5 | Buy | Initiates | $5 | +182.49% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
3.45M
Revenue Next Year
10.60M
from 3.45M
Increased by 207.25%
EPS This Year
-0.28
from -0.29
EPS Next Year
-0.30
from -0.28
EPS and Forward PE are based on non-GAAP adjusted numbers.